- Home
- BEAT vs IOBT Comparison
BEAT vs IOBT Comparison
Compare BEAT & IOBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BEAT
- IOBT
- Stock Information
- Founded
- BEAT 2015
- IOBT 2014
- Country
- BEAT United States
- IOBT Denmark
- Employees
- BEAT N/A
- IOBT N/A
- Industry
- BEAT Retail: Computer Software & Peripheral Equipment
- IOBT Biotechnology: Pharmaceutical Preparations
- Sector
- BEAT Technology
- IOBT Health Care
- Exchange
- BEAT Nasdaq
- IOBT Nasdaq
- Market Cap
- BEAT 65.1M
- IOBT 59.3M
- IPO Year
- BEAT 2021
- IOBT 2021
- Fundamental
- Price
- BEAT $2.08
- IOBT $1.10
- Analyst Decision
- BEAT Buy
- IOBT Strong Buy
- Analyst Count
- BEAT 1
- IOBT 3
- Target Price
- BEAT $8.00
- IOBT $9.33
- AVG Volume (30 Days)
- BEAT 131.3K
- IOBT 119.8K
- Earning Date
- BEAT 03-19-2025
- IOBT 03-04-2025
- Dividend Yield
- BEAT N/A
- IOBT N/A
- EPS Growth
- BEAT N/A
- IOBT N/A
- EPS
- BEAT N/A
- IOBT N/A
- Revenue
- BEAT N/A
- IOBT N/A
- Revenue This Year
- BEAT N/A
- IOBT N/A
- Revenue Next Year
- BEAT N/A
- IOBT N/A
- P/E Ratio
- BEAT N/A
- IOBT N/A
- Revenue Growth
- BEAT N/A
- IOBT N/A
- 52 Week Low
- BEAT $1.35
- IOBT $0.66
- 52 Week High
- BEAT $3.48
- IOBT $1.85
- Technical
- Relative Strength Index (RSI)
- BEAT 39.34
- IOBT 68.67
- Support Level
- BEAT $2.05
- IOBT $0.91
- Resistance Level
- BEAT $2.37
- IOBT $1.14
- Average True Range (ATR)
- BEAT 0.18
- IOBT 0.06
- MACD
- BEAT -0.02
- IOBT 0.02
- Stochastic Oscillator
- BEAT 21.24
- IOBT 87.13
About BEAT Heartbeam Inc.
HeartBeam Inc is a medical technology company primarily focusing on developing and commercializing higher resolution ambulatory Electrocardiogram ("ECG") solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The Company's ability to develop higher-resolution ECG solutions is achieved through the development of the Company's proprietary and patented Vector Electrocardiography ("VECG") technology platform. The Company has validated this technology and is seeking U.S. Food and Drug Administration ("FDA") clearance for its initial telehealth products.
About IOBT IO Biotech Inc.
IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression.